What is he best known for?
The fields of study he is best known for:
- Surgery
- Cancer
- Internal medicine
Yukio Sonoda mainly investigates Surgery, Cervical cancer, Hysterectomy, Endometrial cancer and Ovarian cancer.
Surgery connects with themes related to Stage IIIC in his study.
His Cervical cancer research incorporates themes from Uterine cancer and Retrospective cohort study.
The study incorporates disciplines such as Malignancy, Fertility preservation, Lymphadenectomy and Adjuvant therapy in addition to Hysterectomy.
The concepts of his Endometrial cancer study are interwoven with issues in Sentinel lymph node, Carcinoma, Radiology, Dissection and Sentinel node.
His study in Ovarian cancer is interdisciplinary in nature, drawing from both Multivariate analysis and Porta hepatis.
His most cited work include:
- Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer (479 citations)
- What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC) (463 citations)
- Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm (391 citations)
What are the main themes of his work throughout his whole career to date?
Yukio Sonoda focuses on Surgery, Ovarian cancer, Internal medicine, Stage and Oncology.
His Surgery study integrates concerns from other disciplines, such as Debulking and Cervical cancer.
His Debulking research includes themes of Ovarian carcinoma and Pleural effusion.
His biological study spans a wide range of topics, including Hysterectomy and Obstetrics.
He focuses mostly in the field of Ovarian cancer, narrowing it down to topics relating to Chemotherapy and, in certain cases, Cardiothoracic surgery.
His work in Stage addresses subjects such as Retrospective cohort study, which are connected to disciplines such as Cohort.
He most often published in these fields:
- Surgery (69.45%)
- Ovarian cancer (34.61%)
- Internal medicine (28.88%)
What were the highlights of his more recent work (between 2018-2021)?
- Surgery (69.45%)
- Ovarian cancer (34.61%)
- Debulking (25.54%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Surgery, Ovarian cancer, Debulking, Internal medicine and Oncology.
His Surgery research incorporates elements of Malignancy and Cohort.
Yukio Sonoda has included themes like Resection, Disease, Chemotherapy and Hazard ratio in his Ovarian cancer study.
Yukio Sonoda has researched Debulking in several fields, including Serous Tubal Intraepithelial Carcinoma, Gynecology, Splenectomy and Ovary.
Yukio Sonoda works mostly in the field of Oncology, limiting it down to topics relating to Newly diagnosed and, in certain cases, DNA mismatch repair and Inherited Predisposition.
Yukio Sonoda combines subjects such as Hysterectomy, Cervical cancer and Lymphovascular invasion with his study of Stage.
Between 2018 and 2021, his most popular works were:
- Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes (16 citations)
- Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes (16 citations)
- Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. (8 citations)
In his most recent research, the most cited papers focused on:
- Surgery
- Cancer
- Internal medicine
His scientific interests lie mostly in Surgery, Debulking, Ovarian cancer, Cancer and Internal medicine.
The Stage and Laparotomy research he does as part of his general Surgery study is frequently linked to other disciplines of science, such as Depression, therefore creating a link between diverse domains of science.
His Stage research integrates issues from Cervical cancer and Lymphovascular invasion.
His work deals with themes such as Polypharmacy, Prospective cohort study, Complication and Chemotherapy, which intersect with Debulking.
His study in the fields of Hyperthermic intraperitoneal chemotherapy under the domain of Ovarian cancer overlaps with other disciplines such as In patient.
In his study, BRCA mutation, Germline mutation, Newly diagnosed and Platinum sensitive is inextricably linked to Oncology, which falls within the broad field of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
